Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Select Medical Holdings (SEM) Accumulated Depreciation & Amortization (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $140.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 31.19% to $140.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $140.3 million, a 31.19% decrease, with the full-year FY2025 number at $140.3 million, down 31.19% from a year prior.
  • Accumulated Depreciation & Amortization was $140.3 million for Q4 2025 at Select Medical Holdings, down from $203.9 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.1 billion in Q4 2021 to a low of $140.3 million in Q4 2025.
  • A 5-year average of $379.3 million and a median of $205.8 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 10.11% in 2021, then plummeted 81.91% in 2022.
  • Select Medical Holdings' Accumulated Depreciation & Amortization stood at $1.1 billion in 2021, then tumbled by 81.91% to $205.8 million in 2022, then rose by 1.42% to $208.7 million in 2023, then decreased by 2.32% to $203.9 million in 2024, then tumbled by 31.19% to $140.3 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Accumulated Depreciation & Amortization are $140.3 million (Q4 2025), $203.9 million (Q4 2024), and $208.7 million (Q4 2023).